@article{88158cef54b9471ea3fe40402109812b,
title = "Early triple antiviral therapy for COVID-19",
author = "Nelson Lee and Michael Ison and Jake Dunning",
note = "Funding Information: NL reports non-financial support from Shionogi; personal fees and non-financial support from Janssen Pharmaceuticals, Roche, and Sanofi Pasteur; personal fees and other support from Gilead Sciences and Genetech; and personal fees from Cidara Therapeutics, outside the submitted work. MI reports grants from AiCuris and Shire; grants, personal fees, and other support from Janssen; personal fees and other support from Allovir; personal fees from Celltrion, Roche, Shionogi, Viracor Eurofins; and other support from Merck, Sequiris, Takeda, Vitaeris, SAB Biotherapeutics, outside the submitted work. JD declares no competing interests. ",
year = "2020",
month = nov,
day = "7",
doi = "10.1016/S0140-6736(20)32274-1",
language = "English (US)",
volume = "396",
pages = "1487--1488",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10261",
}